Jubilant Pharmova Ltd vs Vivimed Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Jubilant Pharmova Ltd is ₹ 926.75 as of 30 Apr 15:30 . The P/E Ratio of Jubilant Pharmova Ltd changed from 13 on March 2021 to 16.8 on March 2025 . This represents a CAGR of 5.26% over 5 yearsThe P/E Ratio of Vivimed Labs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Jubilant Pharmova Ltd changed from ₹ 10838 crore on March 2021 to ₹ 14220 crore on March 2025 . This represents a CAGR of 5.58% over 5 yearsThe Market Cap of Vivimed Labs Ltd changed from ₹ 131.42 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Jubilant Pharmova Ltd for the Dec '25 is ₹ 2143 crore as compare to the Sep '25 revenue of ₹ 1976 crore. This represent the growth of 8.44% The revenue of Vivimed Labs Ltd for the Dec '25 is ₹ 15.99 crore as compare to the Sep '25 revenue of ₹ 20.82 crore. This represent the decline of -23.2% The ebitda of Jubilant Pharmova Ltd for the Dec '25 is ₹ 270.2 crore as compare to the Sep '25 ebitda of ₹ 345.3 crore. This represent the decline of -21.75% The ebitda of Vivimed Labs Ltd for the Dec '25 is ₹ -10.92 crore as compare to the Sep '25 ebitda of ₹ -0.74 crore. This represent the growth of 1375% The net profit of Jubilant Pharmova Ltd changed from ₹ 481.8 crore to ₹ 55.8 crore over 7 quarters. This represents a CAGR of -70.83% The net profit of Vivimed Labs Ltd changed from ₹ -15.25 crore to ₹ -16.55 crore over 7 quarters. This represents a CAGR of 4.79% The Dividend Payout of Jubilant Pharmova Ltd changed from 37.14 % on March 2021 to 414.06 % on March 2025 . This represents a CAGR of 61.97% over 5 yearsThe Dividend Payout of Vivimed Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Jubilant Pharmova Ltd

Jubilant Pharmova Limited was initially incorporated as 'Vam Organic Chemicals Limited' on June 21, 1978.
Company name was changed to 'Jubliant Organosys Limited' in November, 2001 and was again changed to 'Jubilant Life Sciences Limited' in October, 2009 and further it attained a new name 'Jubilant Pharmova Limited' in February, 2021. Jubilant Pharmova Limited is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA.

About Vivimed Labs Ltd

Vivimed Labs Limited was originally incorporated on September 22, 1988 as a private limited company in the name of Emgi Pharmaceuticals & Chemicals Pvt Ltd. On April 21, 1994, the company got converted into a public limited company and the name was changed to Emgi Pharmaceuticals & Chemicals Ltd and thereafter, the Company name was finally changed to Vivimed Labs Limited on April 22, 1997. The Company is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry), Pharmaceuticals, API's and Formulations.
The company has strong presence in the areas of Health & Personal Care, Contract Research and Manufacturing.
The company has four subsidiary companies, namely Creative Health Care Pvt Ltd, Vivimed Holdings Ltd (Hong Kong), Vivimed Labs Europe Ltd (UK) and Vivimed Labs USA Inc.

FAQs for the comparison of Jubilant Pharmova Ltd and Vivimed Labs Ltd

Which company has a larger market capitalization, Jubilant Pharmova Ltd or Vivimed Labs Ltd?

Market cap of Jubilant Pharmova Ltd is 14,763 Cr while Market cap of Vivimed Labs Ltd is 56 Cr

What are the key factors driving the stock performance of Jubilant Pharmova Ltd and Vivimed Labs Ltd?

The stock performance of Jubilant Pharmova Ltd and Vivimed Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jubilant Pharmova Ltd and Vivimed Labs Ltd?

As of May 3, 2026, the Jubilant Pharmova Ltd stock price is INR ₹926.75. On the other hand, Vivimed Labs Ltd stock price is INR ₹6.77.

How do dividend payouts of Jubilant Pharmova Ltd and Vivimed Labs Ltd compare?

To compare the dividend payouts of Jubilant Pharmova Ltd and Vivimed Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.